The opportunity to present original research, case series, case reports, and review articles to the San Diego Dermatology Symposium® attendees is an integral part of the conference’s continuing education program. Encore abstracts/posters are permitted. We will allow posters with data that has already been published within the last 6 months, assuming that appropriate copyright permissions are obtained from the journal. Posters will be on display in the conference meeting space as well as listed on the SDDS website until December 31, 2023.
Poster submission is a 2-step process:
Abstract Submission Rules & Guidelines
Submission deadline: 11:59pm Pacific Time on February 3, 2023. After this date/time, the submissions site will close automatically and can no longer accept submissions. There will be no exceptions to this policy.
Abstract submission fee: The fee is $675 per abstract. The fee for residents and fellows is $75 per abstract. Each abstract must be submitted separately. There is no limit on the number of abstracts submitted. Payment is required upon submission of this form. The fee is non-refundable unless your abstract is not accepted, in which case you will receive a full refund.
Format: Abstracts must be submitted as .pdf documents.
File name: must include supporting company name and lead author’s last name.
Margins: 1-inch top, bottom, left and right, single spaced; laser printer quality.
Font: font size must be 12-point Times Roman.
Length: 400 words maximum inclusive of title, author, author's highest degree and affiliations. Abstracts should be a maximum of one 8.5” x 11” page.
Content: Abstracts should reflect content of the poster and must include the poster title. Abstracts should contain the following: a) introduction that states the purpose of the study; b) brief description of the procedure/study; c) brief description of the results; and d) conclusion. Tables/illustrations may not be included in abstracts.
Brand Names: Generic or scientific names of drugs/devices should be used in place of brand names. If brand name is necessary to understand poster content, it should be used only once (after the first mention of the drug or device’s name). Pharmaceutical or other support of any study should be acknowledged at the end of the abstract and at the end of the poster.
Copyright: Copyright is shared. The Dermatology Research and Education Foundation™ owns copyright for its own use. Author(s) retain the rights for all other uses.
Note: If you wish to have your poster posted on the SDDS website only, the fee is $550/per abstract. Pricing is available if interested in additional features such as uploading to the SDDS website: audio slides, audio files/commentaries, and author videos for presentations.
Poster submission is a 2-step process:
- All abstracts will be submitted electronically via the Dermatology Innovation Symposium™ website. Send an abstract of the study by February 3, 2023, which will be reviewed and accepted based on scientific value and educational need. Abstracts may be submitted by dermatologists, dermatology residents and members of industry. Abstracts may be submitted by students for e-posters only. Please allow up to 1 week from date of submission for notification of approval or denial.
- If approved, poster submissions of approved abstracts are electronically due on February 10, 2023. The top 5 posters will be selected for a 5-minute oral presentation during a 30-minute poster session.
Abstract Submission Rules & Guidelines
Submission deadline: 11:59pm Pacific Time on February 3, 2023. After this date/time, the submissions site will close automatically and can no longer accept submissions. There will be no exceptions to this policy.
Abstract submission fee: The fee is $675 per abstract. The fee for residents and fellows is $75 per abstract. Each abstract must be submitted separately. There is no limit on the number of abstracts submitted. Payment is required upon submission of this form. The fee is non-refundable unless your abstract is not accepted, in which case you will receive a full refund.
Format: Abstracts must be submitted as .pdf documents.
File name: must include supporting company name and lead author’s last name.
Margins: 1-inch top, bottom, left and right, single spaced; laser printer quality.
Font: font size must be 12-point Times Roman.
Length: 400 words maximum inclusive of title, author, author's highest degree and affiliations. Abstracts should be a maximum of one 8.5” x 11” page.
Content: Abstracts should reflect content of the poster and must include the poster title. Abstracts should contain the following: a) introduction that states the purpose of the study; b) brief description of the procedure/study; c) brief description of the results; and d) conclusion. Tables/illustrations may not be included in abstracts.
Brand Names: Generic or scientific names of drugs/devices should be used in place of brand names. If brand name is necessary to understand poster content, it should be used only once (after the first mention of the drug or device’s name). Pharmaceutical or other support of any study should be acknowledged at the end of the abstract and at the end of the poster.
Copyright: Copyright is shared. The Dermatology Research and Education Foundation™ owns copyright for its own use. Author(s) retain the rights for all other uses.
Note: If you wish to have your poster posted on the SDDS website only, the fee is $550/per abstract. Pricing is available if interested in additional features such as uploading to the SDDS website: audio slides, audio files/commentaries, and author videos for presentations.
